Neurocrine Biosciences Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (41)

View All

Latest Posts

About This Stock More About This Stock
Are These Biotechs Ready To Launch?
Article By: MoneyShow.com
Saturday, December 9, 2023 12:05 AM EDT
Biotech stocks are still in the process of repairing the damage from recent months — and recent years. Indeed, as of a month ago, the SPDR Biotech Fund had been dead money for an unbelievable eight and a half years
In this article: LLY, NVO, NBIX, XBI, ITCI
Read
5 Top Stocks Set To Beat Earnings Estimates Next Week
Article By: Zacks Investment Research
Saturday, February 1, 2020 12:28 PM EDT
The final three months of last year were quite promising as the U.S.-China trade war finally seemed to ease and strong economic data boosted investors’ sentiments.
In this article: NS, WAT, NBIX, SAVE, RMR
Read
3 Breakout Stocks Of The Last Decade To Consider For 2020
Article By: Zacks Investment Research
Tuesday, December 24, 2019 9:30 AM EDT
The 2010s were a fruitful decade for investors as the S&P 500 has surged over 189% so far. Here is a look at some stocks that were standouts this past decade and look poised to carry that momentum into 2020.
In this article: AVGO, NBIX, NFLX Also: BA, AAPL, AMZN, META
Read
4 Biotech Stocks In Neurology, As Biotechs March On
Article By: Tarun Chandra, CFA
Saturday, December 21, 2019 5:20 PM EDT
In a space of 2-months, biotechs have gone from recording yearly lows in early October, to recording 2019 highs.
In this article: NBIX, ACAD, KRTX, NERV
Read
Biotech (Top 30 Weights) 2019 Earnings Estimates Up 8.58% In Last 2 Months
Article By: T.J. Hayes
Monday, September 9, 2019 7:36 PM EDT
The cumulative earnings power of these 30 stocks was revised UP by 8.58% in the past 60 days.
In this article: ALNY, ALXN, BMRN, CBPO, ILMN, INCY, JAZZ, REGN, SGEN, AMGN, BIIB, CELG, EXEL, GILD, HZNP, MYL, NBIX, TECH, VRTX, AMRN, SAGE, GWPH, SRPT, BLUE, NVCR, IONS, BGNE, PRAH, SYNH, IBB
Read
All Posts

Latest Tweets for $NBIX

No tweets yet!

PARTNER HEADLINES